Abstract:
A method and apparatus for drug dissolution testing may include an overflow vessel with an overflow outlet port at a predetermined height from a bottom of the overflow vessel, a first water bath submerging the overflow vessel and configured to keep a temperature of the overflow vessel at a first predetermined temperature, a pressurized vessel containing a dissolution medium, a second water bath submerging the pressurized vessel and configured to keep the dissolution medium at a second predetermined temperature, a dissolution medium path with an output end connected in fluid communication with the flow cell and an input end attached in fluid communication to the pressurized vessel, where the dissolution medium path may transfer the dissolution medium from the pressurized vessel into the flow cell, a collection vessel connected to the overflow outlet port of the flow cell, and a third water bath submerging the collection vessel and configured to keep the collection vessel at a third predetermined temperature.
Abstract:
The embodiments herein disclose method of synthesizing a composition of controlled drug (antibiotics) release for the treatment of peri-implantitis and periodontal infections which damages the Osseo-integrated dental implant and generates a loss of supporting bone. The combination of metronidazole and amoxicillin overcomes a wide range of pathogens associated with peri-implantitis. A localized biodegradable controlled drug delivery composition is synthesized for treatment of dental and implants infections (peri-implantisis). The system comprises polymer and antibiotics (metronidazole and amoxicillin). The system burst releases antibiotics in the first hours after administration, followed by a controlled release of the antibiotics for a time period up of 3 weeks. The antibiotic concentration is maintained in a suitable therapeutic range. An analysis after 14 days illustrates the elimination of the bacterial biofilm and bactericidal property of the composition.